in 78 patients with bleeding
oesophageal varices (OV) after liver
biopsy performed in 64 of them denoted
that bilharzial fibrosis with cirrhotic liver
is the commonest etiologic factor
(71.8%). Patients with modified Child's
A and B classification were randomly
allocated into group-I managed by
sclerotherapy and group-II subjected to
surgery. Bleeding was controlled in both
groups with no significant statistical
difference, but complete eradication of
the varices was achieved in 86.3% in
group-I and in 32.3% in group-II with
statistically significant difference.
Rebleeding occurred in 13.6% and
17.6%; ascites in 18% and 11.8%;
encephalopathy in 4.5% and 5.9% and
mortality in 15.6% and 20.6% for both
groups respectively, but the differences
in these results were statistically not
significant.
It is considered that sclerotherapy
is a good modality for managing
bleeding OV and also for prevention of
rebleeding. |